[1] Clevers H.The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17(3):313-319.
[2] Yamada H, Takano T, Ito Y,et al.Expression of nestin mRNA is a differentiation marker in thyroid tumors.Cancer Lett. 2009; 280(1):61-64.
[3] Polyak K, Hahn WC.Roots and stems: stem cells in cancer. Nat Med. 2006;12(3):296-300.
[4] Ailles LE, Weissman IL.Cancer stem cells in solid tumors.Curr Opin Biotechnol. 2007;18(5):460-466.
[5] Cho RW, Clarke MF.Recent advances in cancer stem cells. Curr Opin Genet Dev. 2008;18(1):48-53.
[6] Yoon CH, Kim MJ, Lee H,et al.PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.J Biol Chem. 2012;287(23):19516-19527.
[7] Hu X, Ghisolfi L, Keates AC, et al.Induction of cancer cell stemness by chemotherapy.Cell Cycle. 2012;11(14):2691- 2698.
[8] Chien CY, Chuang HC, Chen CH.The side population of cancer stem-like cells in human oral cancer.Oral Oncol. 2012;48(10):913-914.
[9] Hope KJ, Jin L, Dick JE.Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.Nat Immunol. 2004;5(7):738-743.
[10] Singh SK, Hawkins C, Clarke ID,et al.Identification of human brain tumour initiating cells.Nature. 2004;432(7015):396-401.
[11] Ponti D, Costa A, Zaffaroni N,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.Cancer Res. 2005; 65(13): 5506-5511.
[12] Houghton J, Stoicov C, Nomura S,et al.Gastric cancer originating from bone marrow-derived cells.Science. 2004; 306(5701):1568-1571.
[13] O'Brien CA, Pollett A, Gallinger S, et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.Nature. 2007;445(7123):106-110.
[14] Mitsutake N, Iwao A, Nagai K,et al.Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively.Endocrinology. 2007; 148(4):1797-1803.
[15] Todaro M, Iovino F, Eterno V,et al.Tumorigenic and metastatic activity of human thyroid cancer stem cells.Cancer Res. 2010; 70(21):8874-8885.
[16] Lan L, Cui D, Nowka K,et al.Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes.J Clin Endocrinol Metab. 2007;92(9):3681-3688.
[17] Grosse-Gehling P, Fargeas CA, Dittfeld C,et al.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.J Pathol. 2013;229(3): 355-378.
[18] Zito G, Richiusa P, Bommarito A,et al.In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.PLoS One. 2008; 3(10): e3544.
[19] 黄鹏.三种肿瘤干细胞标志物应用于鉴别甲状腺癌病理类型的研究[C].海口:2012全国普通外科新理念新技术研讨会暨海南省医学会第15届外科学术会议论文集,2012.
[20] Liu J, Brown RE.Immunohistochemical detection of epithelial mesenchymal transition associated with stem ness phenotype in anaplastic thyroid carcinoma.Int J Clin Exp Pathol. 2010;3(8):755-762.
[21] Malaguarnera R, Frasca F, Garozzo A,et al.Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.J Clin Endocrinol Me tab. 2011;96(3):766- 774.
[22] Ahn SH, Henderson YC, Williams MD, et al.Detection of thyroid cancer stem cells in papillary thyroid carcinoma.J Clin Endocrinol Me tab. 2014;99(2):536-544.
[23] Munakata W, Nomoto J, Takahashi N,et al. Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation.Am J Surg Pathol. 2012;36(9):1376-1384.
[24] Reya T, Morrison SJ, Clarke MF,et al.Stem cells, cancer, and cancer stem cells.Nature. 2001;414(6859):105-111.
[25] Chaffer CL, Weinberg RA.A perspective on cancer cell metastasis.Science. 2011;331(6024):1559-1564.
[26] Li W, Reeb AN, Sewell WA,et al.Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells.PLoS One. 2013;8(5):e65095.
[27] Kucerova L, Feketeova L, Kozovska Z,et al.In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemo resistant CD133+ tumor-initiating cell subset. Thyroid. 2014;24(3):520-532.
[28] Todaro M, Iovino F, Eterno V,et al.Tumorigenic and metastatic activity of human thyroid cancer stem cells.Cancer Res. 2010; 70(21):8874-8885.
[29] Ke CC, Liu RS, Yang AH,et al.CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radio iodide therapy.Eur J Nucl Med Mol Imaging. 2013;40(1): 61-71.
[30] Wiegand KC, Lee AF, Al-Agha OM,et al.Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas.J Pathol. 2011;224(3):328-333.
[31] Balbás-Martínez C, Rodríguez-Pinilla M, Casanova A,et al.ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.PLoS One. 2013; 8(5):e62483.
[32] Gao X, Tate P, Hu P,et al.ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a.Proc Natl A cad Sci U S A. 2008;105 (18): 6656-6661.
[33] Wang DD, Chen YB, Pan K,et al.Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.PLoS One. 2012;7(7):e40364.
[34] Morel AP, Lièvre M, Thomas C,et al.Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008;3(8):e2888.
[35] Ahmed N, Abubaker K, Findlay J,et al.Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.Curr Cancer Drug Targets. 2010;10(3):268-278.
[36] Du Z, Qin R, Wei C,et al.Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.Dig Dis Sci. 2011;56(3):741-750.
[37] Giannoni E, Bianchini F, Masieri L,et al.Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness.Cancer Res. 2010;70(17):6945-6956.
[38] Thiery JP, Acloque H, Huang RY,et al.Epithelial-mesenchymal transitions in development and disease.Cell. 2009;139(5): 871-890.
[39] Mani SA, Guo W, Liao MJ,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell. 2008;133(4):704-715.
[40] Yang J, Weinberg RA.Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.Dev Cell. 2008;14(6):818-829.
[41] Montemayor-Garcia C, Hardin H, Guo Z,et al.The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.Endocr Pathol. 2013;24(4):206-212.
[42] Vasko V, Espinosa AV, Scouten W,et al.Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.Proc Natl A cad Sci U S A. 2007;104(8):2803-2808.
[43] Buehler D, Hardin H, Shan W,et al.Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.Mod Pathol. 2013;26(1):54-61.
[44] 兰玲,罗勇,崔岱,等.上皮细胞间质样转化对人甲状腺肿瘤干细胞发生的诱导作用[J].中华医学杂志,2013,93(16):1261-1265.
[45] Mani SA, Guo W, Liao MJ,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells.Cell. 2008;133(4):704-715.
[46] De Falco V, Tamburrino A, Ventre S,et al.CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells.Cancer Res. 2012;72(6):1449-1458.
[47] Carina V, Zito G, Pizzolanti G,et al.Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.Thyroid. 2013;23(7):829-837.
[48] Tseng LM, Huang PI, Chen YR,et al.Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.J Pharmacol Exp Ther. 2012;341(2):410-423.
[49] Latini FR, Hemerly JP, Oler G,et al.Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.Endocr Relat Cancer. 2008;15(3):787-799.
[50] Chen G, Xu S, Renko K,et al.Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.J Clin Endocrinol Me tab. 2012;97(4):E510-520.
[51] Dumont JE, Lamy F, Roger P,et al.Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors.Physiol Rev. 1992;72(3):667-697.
[52] Lin RY, Kubo A, Keller GM,et al.Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology. 2003;144(6):2644-2649.
[53] Arufe MC, Lu M, Kubo A,et al.Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology. 2006;147(6):3007-3015.
[54] Jiang N, Hu Y, Liu X,et al.Differentiation of E14 mouse embryonic stem cells into thyrocytes in vitro.Thyroid. 2010; 20(1):77-84.
[55] 李建鑫,杨亮,王文良.脂肪间充质干细胞在组织工程中的应用[J].中国组织工程研究与临床康复,2010,14(7):1274-1277.
[56] Green MD, Chen A, Nostro MC,et al.Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells.Nat Biotechnol. 2011;29(3):267-272.
[57] Uitto J.Regenerative medicine for skin diseases: i PS cells to the rescue.J Invest Dermatol. 2011;131(4):812-814. |